Our Work

With a variety of candidates vying for the Republican presidential nomination and President Joe Biden seeking re-election in the wake of the COVID-19 pandemic, health policy will remain a central issue for voters in the 2024 election.

Melinda sat down to discuss the report on 2022 health care spending from the CMS Office of the Actuary.

Biosimilar uptake in the United States is limited. It has not been comprehensively studied in Medicare Advantage (MA).